Imminent EU CHMP Opinions: Kidney And Breast Cancer, Mastocytosis, MS, Emphysema & Hepatitis C

 
• By Ian Schofield

Among products that are due for a go/no-go recommendation by the European Medicines Agency this week are new drugs for conditions such as cancer, multiple sclerosis, mastocytosis, HIV and hepatitis C.

Recommendation
Products for cancer, mastocytosis, emphysema, hepatitis C and MS are awaiting a CHMP recommendation

More from Product Reviews

More from Pink Sheet